Continuation rate for asenapine and brexpiprazole treatment in elderly patients with schizophrenia

Psychogeriatrics. 2021 Nov;21(6):950-951. doi: 10.1111/psyg.12760. Epub 2021 Sep 5.

Authors

Hidenobu Suzuki¹, Hiroyuki Hibino², Yuichi Inoue³, Atsuhiko Takaya⁴, Katsunaka Mikami⁵, Kenji Yamamoto⁵, Hideo Matsumoto⁵

Affiliations

¹ Department of Psychiatry, Suzuki Clinic, Tokyo, Japan.
² Department of Neuropsychiatry, The University of Tokyo, Tokyo, Japan.
³ Department of Psychiatry, Shakomae Kokorono Clinic, Tokyo, Japan.
⁴ Department of Psychiatry, Fukui Kinen Hospital, Miura, Japan.
⁵ Department of Psychiatry, Course of Specialised Clinical Science, Tokai University School of Medicine, Isehara, Japan.

PMID: 34486199
DOI: 10.1111/psyg.12760

No abstract available

Publication types

Letter

MeSH terms

Aged
Antipsychotic Agents* / adverse effects
Dibenzocycloheptenes
Humans
Quinolones* / therapeutic use
Schizophrenia* / drug therapy
Thiophenes

Substances

Antipsychotic Agents
Dibenzocycloheptenes
Quinolones
Thiophenes
brexpiprazole
asenapine